BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8309985)

  • 1. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
    Rattan AK; Tejwani GA
    Pharmacology; 1994 Jan; 48(1):30-40. PubMed ID: 8309985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
    Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
    Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine.
    Tejwani GA; Hanissian SH
    Neuropharmacology; 1990 May; 29(5):445-52. PubMed ID: 2162496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoarthritis induces complex changes in mu-, delta- and kappa-opioid binding sites in the superficial dorsal horn of the rat spinal cord.
    Besse D; Weil-Fugazza J; Lombard MC; Butler SH; Besson JM
    Eur J Pharmacol; 1992 Nov; 223(2-3):123-31. PubMed ID: 1335878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD; Werling LL; Brown SR; Cox BM
    Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in multiple opioid receptors in regions of the brain in rats treated chronically with thyroxine.
    Bhargava HN; Ramarao P; Gulati A
    Neuropharmacology; 1989 Sep; 28(9):955-60. PubMed ID: 2554187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor binding in rat spinal cord.
    Krumins SA
    Neurochem Res; 1987 Mar; 12(3):231-5. PubMed ID: 3035399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of intrathecal midazolam on morphine-induced antinociception in the rat: role of spinal opioid receptors.
    Rattan AK; McDonald JS; Tejwani GA
    Anesth Analg; 1991 Aug; 73(2):124-31. PubMed ID: 1649558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ethanol on the binding of conformationally rigid and labile ligands of opioid receptors to rat brain membranes.
    Bhargava HN; Rapaka RS; Renugopalakrishnan V
    Biochem Pharmacol; 1988 Jun; 37(11):2279-83. PubMed ID: 2837233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.